Company In the News — Hengrui Pharma
Led by one-half of China’s pharma power couple, Jiangsu Hengrui Medicine Company is attracting international attention with its innovative drugs.
Showing 121 - 132 of 1753
China Hawks Dig In To Bitcoin Mining
Scrutiny of Chinese involvement in crypto mining in the U.S. is growing despite little evidence it can be directed towards nefarious purposes.
The U.S. Must Put Pressure on China to Let the Yuan Strengthen
Europe has borne the brunt of China’s ever-widening trade surplus. The U.S. should join in efforts to respond.
Healthcare AI in China — Medical Miracle or Mirage?
Plus, Chinese crypto miners in the U.S.
Nadia Schadlow on Trump 2.0’s National Security Strategy
The author of Trump's last strategy discusses what's changed and what hasn't on China in the latest report.
“The Reinstitution of Fear”
In an extract from his new book, The Broken China Dream, Minxin Pei looks at how Xi Jinping seized unassailable political power and forced China...
China’s AI Agents Arrive
The country's leading tech and AI firms are racing to develop digital 'co-workers' that can perform a range of jobs.
Foreign Food Brands Seek a Local Flavor in China
From Starbucks to Burger King, multinationals are tapping domestic partners to survive in China’s cutthroat market.
The Future of China’s “Electro-State”
China's advances in key modern industries won't solve its economy's problems and present new challenges for other nations.
Minxin Pei on China’s “Broken Dream”
Also, a way out for struggling barbarian F&B chains?
Marc Hijink on the Nexperia Crisis
The Dutch journalist and author talks about a corporate battle that has pitted the Netherlands against China, and the United States’s role in the saga.
Reverse Deng? For Professionals Only
Countries contemplating letting Chinese firms invest in areas like EVs should seek to emulate China’s strategy in full.